GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
C

CERo Therapeutics Holdings CERO · USD

N/A · US listing · 🇺🇸 United States

Compare

0.00

-18.66%

Close of 5 Nov 2026, in USD

Largest shareholders

As filed, so dates differ, and a group and its funds can both appear.

HolderSharesStakeChangeFiled
Parallel Advisors, LLC220k1.04%+209k30 Jun 2025
Atwood (Brian G)24.6k0.12%+130 Jun 2025
ARCH Venture Partners22.4k0.11%+21.3k30 Jun 2025
Ehrlich (Christopher B)2.9k0.01%+230 Jun 2025
UBS Financial Services, Inc.2.6k0.01%+49130 Jun 2025
FNY Investment Advisers LLC1.1k0.00%+1k30 Jun 2025
Tower Research Capital LLC6840.00%+43330 Jun 2025
LaPorte (Kathleen D)4860.00%—30 Jun 2025
SBI Securities Co., Ltd.180.00%+1230 Jun 2025
Edward Jones30.00%+330 Jun 2025
BofA Global Research (US)20.00%+130 Jun 2025

Short interest

Shares sold short, 15 Oct 2026. US exchange data.

1k

-91.9% on the period before. 1.0 days to cover.

Short volume

Share of the day's trading sold short, 30 Oct 2025

82.0%

Last 8 trading days.

Failed deliveries

Shares not delivered on settlement, from the SEC

  • 23 Sept 2026977 shares
  • 16 Sept 2026989 shares
  • 15 Sept 202685 shares
  • 4 Sept 2026651 shares
  • 3 Sept 2026201 shares

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.